XM does not provide services to residents of the United States of America.

Indian shares likely to open higher



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-Indian shares likely to open higher</title></head><body>

BENGALURU, Sept 16 (Reuters) -Indian shares are set to open higher on Monday, with traders expecting the quantum of a likely U.S. Federal Reserve rate cut to influence market trajectory as a deeper reduction could attract more foreign inflows.

The GIFT Nifty GIFc1 was at 25,437.5 points, as of 08:03 a.m. IST, indicating the NSE Nifty 50 .NSEI will open above Friday's closing high of 25,356.5.

Benchmark indexes Nifty 50 and S&P BSE Sensex .BSESN closed flat on Friday, but logged their best week since the end of June ahead of a likely U.S. rate cut this week.

The odds of a 50-basis-point Fed rate cut have risen to 59% from 30% a week earlier.

An aggressive 50-bps rate cut could bring in additional foreign inflows and boost domestic equities, two traders said.

Foreign institutional investors were net buyers of Indian stocks for a fifth consecutive session on Friday, purchasing shares worth 23.65 billion rupees ($282 million), while domestic institutional investors purchased shares worth 25.32 billion rupees.

Other Asian markets were subdued, with the MSCI Asia ex-Japan index .MIAPJ0000PUS also trading flat. Wall Street equities closed higher on Friday as the prospect of an aggressive 50-bps rate cut rose, helped by comments from key Fed officials.



STOCKS TO WATCH


** Laurus Labs LAUL.NS: U.S. drug regulator concluded audit of company's active pharma ingredients (API) manufacturing facility at Hyderabad with no observations. nFWN3KV0HL

** Zydus Lifesciences ZYDU.NS: Drugmaker secures licensing and supply agreement for magnetic resonance imaging (MRI) contrast agents in the U.S. nTUA6FWHYZ

** Dixon Technologies DIXO.NS: Company's unit Padget enters into a deal with Asus for manufacturing of notebooks. nFWN3KV03Z




($1 = 83.9120 Indian rupees)



Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sherry Jacob-Phillips

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.